MESA LABORATORIES INC /CO/

MLAB

$525M

Small Cap

NASDAQIndustrial Instruments For Measurement, Display, and Control🇺🇸North AmericaLAKEWOOD

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Aug 4, 2026

26d

Market Overview

Stock performance and key metrics

MLAB News

Catalyst Timeline

1 upcoming, 0 past

No catalysts found.

1 more catalyst beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

How MLAB's past catalysts played out

earningsMay 2026-14%earningsFeb 2026+9%earningsAug 2025-25%earningsMay 2025-9%earningsNov 2024-12%earningsFeb 2024+6%earningsAug 2023+5%earningsMay 2023-6%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is MESA LABORATORIES INC /CO/'s next FDA catalyst?→

MESA LABORATORIES INC /CO/'s (MLAB) next tracked catalyst is a Earnings expected August 4, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track MLAB biotech catalysts?→

Add MLAB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MESA LABORATORIES INC /CO/'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply